1. Home
  2. ELTK vs XLO Comparison

ELTK vs XLO Comparison

Compare ELTK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$8.15

Market Cap

62.5M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.97

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
XLO
Founded
1970
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
56.9M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
ELTK
XLO
Price
$8.15
$8.97
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
3.9K
9.5K
Earning Date
05-19-2026
05-14-2026
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
589.88
52 Week Low
$7.30
$0.46
52 Week High
$11.59
$9.90

Technical Indicators

Market Signals
Indicator
ELTK
XLO
Relative Strength Index (RSI) 47.38 47.21
Support Level $7.68 $8.52
Resistance Level $9.15 $9.22
Average True Range (ATR) 0.44 0.29
MACD 0.03 -0.03
Stochastic Oscillator 42.96 53.33

Price Performance

Historical Comparison
ELTK
XLO

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: